Rory Riggs, MBA
Mr. Riggs is co-founder and chairman of the investment committee of Royalty Pharma, an investment company focused on drug royalties; Chief Executive Officer, Founder of Locus Analytics/Syntax, a development stage venture focused on creating a new information technology platform for business and large-scale portfolio management. He has served as President and director of Biomatrix, Inc., a publicly-traded biopharmaceutical company; Chief Executive Officer of RF&P Corporation, an investment company owned by the State of Virginia Retirement System; and a Managing Director in PaineWebber’s mergers and acquisitions department. In addition, Mr. Riggs serves as Managing Member of New Ventures, a venture fund focused on healthcare; and on the board of directors of FibroGen, Inc. (publicly-traded); Intra-Cellular Therapies (publicly-traded); Cibus, LLC (Chairman, private); GeneNews (publicly-traded); and eReceivables (private). He graduated from Middlebury College and holds an MBA from Columbia University.